BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7083473)

  • 1. Phagocytosis of particulate nickel compounds by rat peritoneal macrophages in vitro.
    Kuehn K; Fraser CB; Sunderman FW
    Carcinogenesis; 1982; 3(3):321-6. PubMed ID: 7083473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity of nickel compounds in animals.
    Sunderman FW
    IARC Sci Publ; 1984; (53):127-42. PubMed ID: 6532978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution half-times of nickel compounds in water, rat serum, and renal cytosol.
    Kuehn K; Sunderman FW
    J Inorg Biochem; 1982 Aug; 17(1):29-39. PubMed ID: 7119773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between erythrocytosis and renal cancers in rats following intrarenal injection of nickel compounds.
    Sunderman FW; McCully KS; Hopfer SM
    Carcinogenesis; 1984 Nov; 5(11):1511-7. PubMed ID: 6488475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenesis tests of nickel arsenides, nickel antimonide, and nickel telluride in rats.
    Sunderman FW; McCully KS
    Cancer Invest; 1983; 1(6):469-74. PubMed ID: 6667417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocytosis, cellular distribution, and carcinogenic activity of particulate nickel compounds in tissue culture.
    Costa M; Simmons-Hansen J; Bedrossian CW; Bonura J; Caprioli RM
    Cancer Res; 1981 Jul; 41(7):2868-76. PubMed ID: 7248947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of surface charge and dissolution on the selective phagocytosis of potentially carcinogenic particulate metal compounds.
    Heck JD; Costa M
    Cancer Res; 1983 Dec; 43(12 Pt 1):5652-6. PubMed ID: 6640519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenesis bioassays of nickel oxides and nickel-copper oxides by intramuscular administration to Fischer-344 rats.
    Sunderman FW; Hopfer SM; Plowman MC; Knight JA
    Res Commun Chem Pathol Pharmacol; 1990 Oct; 70(1):103-13. PubMed ID: 2263758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic dissolution of phagocytized crystalline nickel sulfide particles: a prerequisite for nuclear uptake of nickel.
    Abbracchio MP; Simmons-Hansen J; Costa M
    J Toxicol Environ Health; 1982 Apr; 9(4):663-76. PubMed ID: 7108981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunotoxicity of three nickel compounds following 13-week inhalation exposure in the mouse.
    Haley PJ; Shopp GM; Benson JM; Cheng YS; Bice DE; Luster MI; Dunnick JK; Hobbs CH
    Fundam Appl Toxicol; 1990 Oct; 15(3):476-87. PubMed ID: 2258012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocytosis of nickel subsulfide particles during the early stages of neoplastic transformation in tissue culture.
    Costa M; Mollenhauer HH
    Cancer Res; 1980 Aug; 40(8 Pt 1):2688-94. PubMed ID: 7388819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of various nickel compounds in rat organs after oral administration.
    Ishimatsu S; Kawamoto T; Matsuno K; Kodama Y
    Biol Trace Elem Res; 1995 Jul; 49(1):43-52. PubMed ID: 7577320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron microprobe in vitro study of interaction of carcinogenic nickel compounds with tumour cells.
    Berry JP; Galle P; Poupon MF; Pot-Deprun J; Chouroulinkov I; Judde JG; Dewally D
    IARC Sci Publ; 1984; (53):153-64. PubMed ID: 6099827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical responses of rat and mouse lung to inhaled nickel compounds.
    Benson JM; Burt DG; Cheng YS; Hahan FF; Haley PJ; Henderson RF; Hobbs CH; Pickrell JA; Dunnick JK
    Toxicology; 1989 Aug; 57(3):255-66. PubMed ID: 2756527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of dissolution of nickel subsulfide in rat serum.
    Kasprzak KS; Sunderman FW
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):95-108. PubMed ID: 841185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cytotoxicity of four nickel compounds to canine and rodent alveolar macrophages in vitro.
    Benson JM; Henderson RF; McClellan RO
    J Toxicol Environ Health; 1986; 19(1):105-10. PubMed ID: 3746937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of nickel subsulfide during carcinogenesis studied by autoradiography and X-ray powder diffraction.
    Oskarsson A; Andersson Y; Tjälve H
    Cancer Res; 1979 Oct; 39(10):4175-82. PubMed ID: 476653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of manganese compounds on carcinogenicity of nickel subsulfide in rats.
    Sunderman FW; McCully KS
    Carcinogenesis; 1983; 4(4):461-5. PubMed ID: 6839419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenicity of nickel(II)hydroxides and nickel(II)sulfate in Wistar rats and its relation to the in vitro dissolution rates.
    Kasprzak KS; Gabryel P; Jarczewska K
    Carcinogenesis; 1983; 4(3):275-9. PubMed ID: 6831634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Nickel Subsulfide (CAS No. 12035-72-2) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 453():1-365. PubMed ID: 12594522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.